DiabetesJuly 16, 20268 min read
Best GLP-1 for Men With Type 2 Diabetes in 2026
Key Takeaways
- Several GLP-1s are approved for both diabetes and weight loss — Mounjaro/Zepbound (tirzepatide), Ozempic/Wegovy (semaglutide)
- Tirzepatide (Mounjaro) shows slightly superior A1C reduction vs. semaglutide in head-to-head trials
- Insurance coverage is often better for diabetes indication than weight loss
- Compounded options at $89-133/mo provide an alternative if insurance doesn't cover brand-name
- Men with type 2 diabetes and obesity get dual benefit: glucose control + weight loss + potential testosterone improvement
Men with type 2 diabetes have a unique advantage with GLP-1 medications: the same drug treats both their metabolic condition and excess weight. Here's how to choose the right one.
GLP-1 Options for Type 2 Diabetes
| Product | Diabetes Approved? | Weight Loss Approved? | A1C Reduction |
|---|---|---|---|
| Mounjaro (tirzepatide) | Yes | Yes (as Zepbound) | -2.0 to -2.4% |
| Ozempic (semaglutide) | Yes | Yes (as Wegovy) | -1.5 to -1.8% |
| Rybelsus (oral semaglutide) | Yes | Off-label for weight | -1.0 to -1.4% |
| Compounded semaglutide | Off-label | Off-label | Varies |
Bottom Line
Men with type 2 diabetes should leverage the dual-indication advantage: get your GLP-1 prescribed for diabetes (better insurance coverage), enjoy the weight loss and potential testosterone improvement as bonuses. Tirzepatide (Mounjaro) has the edge on A1C reduction; semaglutide (Ozempic) has more cardiovascular data. Either is an excellent choice for diabetic men.
GM
GLP-1Men Editorial
Male-focused GLP-1 research. Testosterone, muscle preservation, and men's metabolic health. Not medical advice.
Medical Disclaimer: Informational only. GLP-1s require a licensed provider. Compounded medications are not FDA-approved. Consult your physician.